Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Prosoma

Explore full profile

Digital mental health support for cancer patients

Szczecin, PolandFounded 2017Health Tech & Medtech
Valuation $25–50M Last recorded · 2025
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Prosoma and the history behind them.

About Prosoma

Prosoma is a digital health company that develops certified medical applications to provide mental health support and behavioral therapy for cancer patients. Founded in 2017 by Marek Ostrowski and Emanuela Kufel, and officially established in 2018, the company is dedicated to improving the quality of life for individuals undergoing cancer treatment. Marek Ostrowski, a psycho-oncologist and serial entrepreneur, provides the driving vision, while Emanuela Kufel brings experience in healthcare communications. The team also includes co-founders Andrzej Jonczyk and Piotr Grudzinski.

The company's core product is "Living Well," a Class I medical device and self-care mobile application that delivers a clinically validated, personalized therapeutic program. This program is designed to help patients manage symptoms of stress, anxiety, and depression related to their diagnosis and treatment. The app includes interactive educational content, relaxation exercises, and tools based on Cognitive Behavioral Therapy (CBT) and mindfulness to help users build healthy habits. Prosoma's platform is designed for a range of users, including patients, physicians, healthcare providers, and pharmaceutical companies. The business model focuses on making the digital therapy prescribable by doctors and reimbursable by healthcare systems. The "Living Well" app is already reimbursed by some statutory health insurance providers in Germany.

Prosoma has secured multiple rounds of funding, including a Pre-Series A round of €4.4 million, to scale its operations in the DACH region (Germany, Austria, Switzerland) and expand into the U.S. market. The company collaborates with an interdisciplinary team of scientists, psychologists, and engineers to ensure its products meet the highest clinical, technical, and data security standards, including GDPR, ISO 13485, and ISO/IEC 27001.

Source: Dealroom company data

At a glance

Founded
2017
Headquarters
Szczecin, Poland
Sector
Health Tech & Medtech

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed9 investors entered at this stage

  • Black Pearls VC
  • Pomerangels
  • RST Ventures For Earth
  • The National Centre for Research and Development
  • EIT Health
  • Impact Ventures Hungary
  • Verge HealthTech Fund
  • Smartlink Partners
  • Convergence Partners

Series A4 investors entered at this stage

  • YouNick Mint
  • Simpact VC
  • Impact Ventures
  • CRB Health Tech
Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇵🇱 Poland60%
🇺🇸 United States12%
🇨🇭 Switzerland4%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Prosoma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Prosoma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.